{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:29:50Z","timestamp":1759073390597},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,30]]},"DOI":"10.7759\/cureus.44376","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T13:03:03Z","timestamp":1693400583000},"source":"Crossref","is-referenced-by-count":4,"title":["Cutaneous Leukocytoclastic Vasculitis Induced by Apixaban and\/or Rivaroxaban With Seronegative Anti-Neutrophil Cytoplasmic Antibody (ANCA) Titers: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Mohamad","family":"El-Sabbagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainalabedeen M","family":"Sabah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M","family":"Tarakji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad O","family":"Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin M","family":"Denig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diagnosis and treatment of cutaneous leukocytoclastic vasculitis","volume":"8","author":"Gota CE","year":"2013","unstructured":"Gota CE, Calabrese LH. Diagnosis and treatment of cutaneous leukocytoclastic vasculitis. Int J Clin Rheumatol. 2013, 8:49-60.","journal-title":"Int J Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000503990","article-title":"Methimazole-induced leukocytoclastic vasculitis: a case report","volume":"11","author":"Tawanwongsri W","year":"2019","unstructured":"Tawanwongsri W, Chayavichitsilp P. Methimazole-induced leukocytoclastic vasculitis: a case report. Case Rep Dermatol. 2019, 11:303-309. 10.1159\/000503990","journal-title":"Case Rep Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01371-3","article-title":"Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report","volume":"20","author":"Buck M","year":"2020","unstructured":"Buck M, Dumic I, McDermott W, et al.. Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report. BMC Gastroenterol. 2020, 20:240. 10.1186\/s12876-020-01371-3","journal-title":"BMC Gastroenterol"},{"key":"ref4","article-title":"Leukocytoclastic vasculitis","author":"Baigrie D","year":"2023","unstructured":"Baigrie D, Goyal A, Crane JS. Leukocytoclastic vasculitis. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-4-204","article-title":"Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report","volume":"4","author":"Brown K","year":"2010","unstructured":"Brown K, Martin J, Zito S. Severe leukocytoclastic vasculitis secondary to the use of a naproxen and requiring amputation: a case report. J Med Case Rep. 2010, 4:204. 10.1186\/1752-1947-4-204","journal-title":"J Med Case Rep"},{"key":"ref6","unstructured":"Evaluation of adults with cutaneous lesions of vasculitis. (2022). Accessed. November 28, 2022: https:\/\/www.uptodate.com\/contents\/evaluation-of-adults-with-cutaneous-lesions-of-vasculitis\/print."},{"key":"ref7","unstructured":"Clinical spectrum of antineutrophil cytoplasmic autoantibodies. (2022). Accessed. November 28, 2022: https:\/\/www.uptodate.com\/contents\/clinical-spectrum-of-antineutrophil-cytoplasmic-autoantibodies."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000539","article-title":"Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"132","author":"Weng CH","year":"2019","unstructured":"Weng CH, Liu ZC. Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Chin Med J (Engl). 2019, 132:2848-2855. 10.1097\/CM9.0000000000000539","journal-title":"Chin Med J (Engl)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.2.155","article-title":"Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis","volume":"142","author":"Bahrami S","year":"2006","unstructured":"Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol. 2006, 142:155-161. 10.1001\/archderm.142.2.155","journal-title":"Arch Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.12.007","article-title":"Apixaban causing leukocytoclastic vasculitis","volume":"6","author":"Nasir UB","year":"2018","unstructured":"Nasir UB, Kumar A, Easwar A. Apixaban causing leukocytoclastic vasculitis. J Allergy Clin Immunol Pract. 2018, 6:1744-1745. 10.1016\/j.jaip.2017.12.007","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7234069","article-title":"Apixaban as a rare cause of leukocytoclastic vasculitis","volume":"2020","author":"Spears J","year":"2020","unstructured":"Spears J, Chetrit DA, Manthey S, Lee C, Al-Saiegh Y. Apixaban as a rare cause of leukocytoclastic vasculitis. Case Rep Rheumatol. 2020, 2020:7234069. 10.1155\/2020\/7234069","journal-title":"Case Rep Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2016.0353","article-title":"Leukocytoclastic vasculitis associated with a new anticoagulant: rivaroxaban","volume":"34","author":"Hasbal NB","year":"2017","unstructured":"Hasbal NB, Ba\u015ft\u00fcrk T, Ko\u00e7 Y, Sahuto\u011flu T, Bayrakdar \u00c7a\u011flayan F, \u00dcnsal A. Leukocytoclastic vasculitis associated with a new anticoagulant: rivaroxaban. Turk J Haematol. 2017, 34:116-117. 10.4274\/tjh.2016.0353","journal-title":"Turk J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.03.012","article-title":"Rivaroxaban-induced leukocytoclastic vasculitis: a challenging rash","volume":"116","author":"Chaaya G","year":"2016","unstructured":"Chaaya G, Jaller-Char J, Ghaffar E, Castiglioni A. Rivaroxaban-induced leukocytoclastic vasculitis: a challenging rash. Ann Allergy Asthma Immunol. 2016, 116:577-578. 10.1016\/j.anai.2016.03.012","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146082-cutaneous-leukocytoclastic-vasculitis-induced-by-apixaban-andor-rivaroxaban-with-seronegative-anti-neutrophil-cytoplasmic-antibody-anca-titers-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:03Z","timestamp":1707508683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146082-cutaneous-leukocytoclastic-vasculitis-induced-by-apixaban-andor-rivaroxaban-with-seronegative-anti-neutrophil-cytoplasmic-antibody-anca-titers-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.44376","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,30]]}}}